Company page
Ribomic, Inc.
Ribomic, Inc. is a public company traded under the ticker 4591 in the Japanese market. The company has a market capitalization of approximately 21.7 million USD. Ribomic focuses on developing innovative therapeutic solutions, leveraging its proprietary RNA-targeting technology.
- Ticker
- 4591:TSE
- Asset type
- Stock
- Market cap
- $21.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSE
- Currency
- JPY